K2 Principal Fund’s Dimension Therapeutics, Inc DMTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-160,000
Closed -$960K 421
2017
Q3
$960K Buy
+160,000
New +$415K 0.06% 215

K2 Principal Fund's DMTX Position: Q4 2017 in Review

K2 Principal Fund sold out of Dimension Therapeutics, Inc (DMTX) in Q4 2017, closing a stake of 160,000 shares — an estimated $960K sold.

K2 Principal Fund first reported a position in DMTX in Q3 2017 and held it in 1 quarter. The position peaked at $960K in Q3 2017. 0 funds tracked by Wall St. Rank hold DMTX as of Q4 2017.

  • K2 Principal Fund reported no remaining Dimension Therapeutics, Inc position as of Q4 2017 after selling out during the quarter.
  • K2 Principal Fund sold 160,000 Dimension Therapeutics, Inc shares in Q4 2017, an estimated $960K.
  • K2 Principal Fund first reported a position in Dimension Therapeutics, Inc in Q3 2017 and held it in 1 quarter.
  • K2 Principal Fund's Dimension Therapeutics, Inc position peaked at $960K in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Dimension Therapeutics, Inc as of Q4 2017.

Based on K2 Principal Fund's 13F filing for Q4 2017, filed 12 Feb 2018.